We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Class Action Suit Claims Celgene Gamed the System to Guard Thalomid, Revlimid Monopolies
Class Action Suit Claims Celgene Gamed the System to Guard Thalomid, Revlimid Monopolies
A health plan for a carpenters’ union filed a class action lawsuit against Celgene, claiming the drugmaker engaged in anti-competitive practices to maintain its monopoly on Thalomid and Revlimid.